Prescription Drug Search
Product Request Form
Campath is currently not available.
Our suppliers are constantly updating their product inventory and availability status. If you would like us to notify you when Campath becomes available, please fill out the form below.
*We value your privacy! We will never give, lease, sell or otherwise disclose your personal information. Period!
Browse Alphabetically:
A
·
B
·
C
·
D
·
E
·
F
·
G
·
H
·
I
·
J
·
K
·
L
·
M
·
N
O
·
P
·
Q
·
R
·
S
·
T
·
U
·
V
·
W
·
X
·
Y
·
Z
·
#
Information about GlobalPharmacyMeds.to
List of countries where we can ship Campath:
- Antigua and Barbuda
- Armenia
- Austria
- Azerbaijan
- Belize
- Bosnia and Herzegovina
- Cayman Islands
- Chile
- Costa Rica
- Croatia
- Cyprus
- Czech Republic
- Egypt
- El Salvador
- France
- Germany
- Guam
- Hungary
- India
- Iran
- Iraq
- Ireland
- Jamaica
- Liechtenstein
- Lithuania
- Malta
- Nicaragua
- Portugal
- Russian Federation
- Serbia
- Seychelles
- Slovakia
- Tonga
- Trinidad and Tobago
- United Arab Emirates
- United Kingdom, UK
- United States, US
- Uruguay
- Uzbekistan
- Venezuela
Latest news releases on Campath:
Campath.com Consumer Home
Campath, alemtuzumab is a major step forward in the treatment of B-cell chronic lymphocytic leukemia (B-CLL).
Alemtuzumab - Wikipedia
Alemtuzumab is a drug used in the treatment of chronic lymphocytic leukemia (CLL), cutaneous T-cell lymphoma (CTCL) and T-cell lymphoma under the trade names Campath, ...
Dosing and Administration - Campath.com Consumer Home
Premedicate with diphenhydramine (50 mg) and acetaminophen (500 mg to 1000 mg) 30 minutes prior to first infusion and each dose escalation.
Campath Distribution Program (US HCPs Only) Provider Portal
The Campath Distribution Program was developed to ensure continued access to Campath ® (alemtuzumab) for appropriate patients. Effective September 4, 2012 Campath is ...
Campath (ALEMTUZUMAB) Package Insert
WARNING. Campath should be administered under the supervision of a physician experienced in the use of antineoplastic therapy. Hematologic Toxicity: Serious and, in ...
Alemtuzumab (Campath) - Medical Clinical Policy Bulletins ...
Number: 0764. Policy. Aetna considers alemtuzumab (Campath) medically necessary for the treatment of any of the following conditions:
Campath (alemtuzumab) 30 mg/ml, solution a diluer pour ...
ANSM – Genzyme septembre 2012 Version 2 3/56 PUT ATU nominative Campath 1. Le suivi et la surveillance des patients traités : tous les patients recevant le ...
Sanofi withdraws Campath in US and EU - PharmaTimes
French drugmaker Sanofi's Genzyme unit is pulling its cancer drug Campath/MabCampath from markets on both sides of the Atlantic in order to optimise the pending ...
Alemtuzumab - Wikipedia
Cenni storici. Le origini di alemtuzumab risalgono al Campath-1 che era un derivato da anticorpi di topo specifico contro le proteine di linfociti umani, prodotto ...
Renal Medicine: Renal Prescribing
References: Electronic Medicines Compendium (eMC) Renal Drug Handbook. Ashley C, Currie A.Third Edition. Radcliffe Publishing. 2009 . Disclaimer: The information ...
